Tiziana Life Sciences (TLSA) Non-Current Assets (2017 - 2025)

Tiziana Life Sciences (TLSA) has reported Non-Current Assets for 9 consecutive years, with $2.9 million the latest figure, recorded in Q4 2025.

• Quarterly Non-Current Assets rose 18293.75% year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.2 million (up 76287.5% YoY) and the FY2025 annual result came in at $2.9 million, up 18293.75% from the prior year.
• Non-Current Assets advanced to $2.9 million in Q4 2025 per TLSA's latest filing, from $18000.0 in the prior quarter.
• Over the last five years, Non-Current Assets for TLSA reached as high as $4.8 million in Q4 2023 and fell as low as $16000.0 in Q2 2024.
• A 5-year average of $1.6 million and a median of $1.5 million in 2022 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2024 — Non-Current Assets tumbled 99.67% — and 2025, when it surged 18293.75%.
• Year by year, Non-Current Assets stood at $147000.0 in 2021, then surged by 1393.2% to $2.2 million in 2022, then surged by 120.82% to $4.8 million in 2023, then slumped by 99.67% to $16000.0 in 2024, then jumped by 18293.75% to $2.9 million in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $2.9 million, $18000.0, and $16000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.